Form 4 for LONA LeonaBio, Inc.
Accepted 2022-10-17 00:00:00 ET · period of report 2022-10-13 · accession 0001209191-22-053869 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-10-17 | 2022-10-13 | LONA | MOEBIUS HANS | Chief Medical Off | M - OptEx | $1.35 | +7,881 | 60.8K | +15% | +$10.6K |
| D | 2022-10-17 | 2022-10-13 | LONA | MOEBIUS HANS | Chief Medical Off | M - OptEx | $0.00 | -7,881 | 7,882 | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-10-13 | M | A | 7,881 | $1.35 | 60,836 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2022-10-13 | M | D | 7,881 | $0.00 | 7,882 | D | $1.35 · — to 2029-08-14 | 7,881 Common Stock | (F1) One-fourth of the shares subject to the option vested on June 1, 2020 and one-fourth of the shares subject to the option vest on each year thereafter. |